AbbVie Highlights Blood Cancer Data From Its Growing Oncology Pipeline at the 64th ASH Annual Meeting Pharmaceutical Investing
U.S. FDA Accepts for Priority Review the Biologics License Application for Epcoritamab for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma Pharmaceutical Investing
Bristol Myers Squibb Data at ASH 2022 Highlight Innovative Therapeutic Platforms Across a Range of Blood Diseases Pharmaceutical Investing
Sirona Biochem Reports Positive Results in Safety Study for Anti-Aging Compound TFC-1326 Life Science Investing
Canadian Migraine Sufferers Have New Treatment Option - Health Canada Approves UBRELVY® Pharmaceutical Investing
Mindset Pharma and PharmAla Enter into Exclusive Sales Agreement for the Sale and Distribution of Pharmaceutical Grade Psilocybin Life Science Investing
BriaCell CEO Discusses Positive Clinical Results of its Breast Cancer Immunotherapy Treatment in an Audio Interview with SmallCapVoice.com Pharmaceutical Investing
